Thanks for that little piece Nike.”they are scrambling for new...

Thanks for that little piece Nike.
”they are scrambling for new potential blockbusters
to replace those that are nearing sales decline”

Now we have all heard this before, but to read it
again reinforces our disbelief that no potential
partner/partners have laid a lucrative offer on
the table for the major part of the action with
Zilosul. What are they seeing or not seeing
that we as shareholders are seeing or not
seeing?

Are they seeing that our IP protection and
agreement with Bene are shaky?

Do they believe that iPPS is not efficacious
enough and that the trial results so far are not
impressive enough?

Do they think there are other drugs in the
pipeline that maybe be more effective and
show more commercial promise?

Do they now see PAR as a total s**t show
and not worth dealing with? Just pick up the
pieces when it lands in a heap?

I’ll wager that PAR management know the real
reason/reasons after their supposed exhaustive
discussions with BP, but they won’t tell us
peasants for fear of “scaring the horses”
further.